AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Phase III study for kidney cancer vaccine analyzed.
2004 JAN 21 - (NewsRx.com & NewsRx.net) -- Antigenics Inc. (NASDAQ: AGEN), which is developing personalized immunotherapeutics and treatments for cancers and other diseases, announced that the Data Monitoring Committee (DMC) convened as scheduled for the interim analysis of a Phase III clinical trial of the company's personalized cancer vaccine Oncophage (HSPPC-96) in the treatment of renal cell carcinoma.
The DMC recommended that the trial proceed as planned and saw no need to change the patient accrual goals for a successful analysis of the randomized Phase III trial. The DMC declared the design and conduct of the trial sound and raised no safety concerns.
The trial, taking place at 132 centers worldwide and involving more than 650 patients, is believed to be the most extensive study of adjuvant therapy in patients with RCC to date, as well as the largest clinical trial of any patient-specific treatment tested.
"We are most encouraged and pleased by the DMC's recommendations. Antigenics hopes to bring this treatment to RCC patients in the near future," said Garo H. Armen, PhD, chairman and CEO of Antigenics.
The randomized, ...
- Significant survival advantage reported in phase III trial of Theratope.
- Newspaper article from: Vaccine Weekly July 7, 2004 700+ words
...Theratope vaccine as part of Biomira's phase III study of the vaccine in the treatment...breast cancer. Updated results from the phase III trial, including the exploratory analysis...we will be required to do a subsequent phase III study in order to move this product to...
- Prostate cancer vaccine on track for phase III clinical trials.
- Newspaper article from: Vaccine Weekly November 27, 2002 700+ words
...manufacturing facilities for phase III trials and market launch...is on track to enter phase III clinical trials by mid...expects to initiate a phase III clinical trial by mid...article was prepared by Vaccine Weekly editors from staff and...
- VaxGen's phase III trial in Thailand clears final scheduled safety review.
- Newspaper article from: Vaccine Weekly December 11, 2002 700+ words
...conduct review of the company's phase III trial in Thailand and once again...announced. VaxGen is conducting two phase III trials, one in Thailand and another...This article was prepared by Vaccine Weekly editors from staff and other reports...
- Neurocrine Biosciences Ramps Up Phase III Clinical Trials for NBI-34060 In...
- Press release article from: PR Newswire March 19, 2002 700+ words
...is initiating three additional pivotal Phase III clinical trials of NBI-34060 Immediate...1200 patients. The Company's first Phase III study with NBI-34060-IR was previously...currently be conducting four of eight planned Phase III clinical trials with NBI-34060. According...
- Phase III Medical Announces Appointment of Harvard's Dr. Wayne Marasco as...
- Press release article from: Business Wire November 23, 2004 700+ words
MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM...Marasco joined the Board of Directors of Phase III Medical in June 2003. He is an Associate...biographical information on Dr. Marasco and Phase III Medical, please refer to the Company...
- CMS Releases Stark Phase III Regulations.(United States. Centers for Medicare...
- News wire article from: Mondaq Business Briefing September 4, 2007 700+ words
...copy of the long-awaited Stark II Phase III Regulations. Overall, healthcare providers should be pleased with the Phase III Stark rules. Despite fears that...would be drastically altered, the Phase III revisions are for the most part...
- Phase III Medical Completes Acquisition of NeoStem, Inc., an Adult Stem Cell...
- Press release article from: Business Wire January 26, 2006 700+ words
MELVILLE, N.Y. -- Phase III Medical, Inc. (Phase III) (OTCBB:PHSM), has completed the acquisition of...stem cells. Pursuant to the terms of the acquisition, Phase III, through its wholly owned subsidiary, has purchased...
- Pain Therapeutics Announces Fourth Quarter and Year End 2004 Financial Results;...
- Press release article from: PR Newswire January 26, 2005 700+ words
...We ended the year with three drugs in Phase III clinical trials, nearly $100 million...results now set the stage for a series of Phase III clinical announcements in 2005. After...look forward to unblinding data from our Phase III trials and announcing clinical results...
- Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache...
- Press release article from: Business Wire September 11, 2008 700+ words
-- Phase III Studies Show Statistically Significant...completed a top-line analysis of its two Phase III clinical trials exploring the use of...pleased with the top-line results of our Phase III clinical trials which show that BOTOX...
- InterMune Provides Update on Its Two Phase III Pulmonology Programs.
- Press release article from: PR Newswire October 17, 2005 700+ words
- Phase III INSPIRE Trial on Track to Conclude Around the End of 2007 - - Design of Phase III Pirfenidone Program Finalized - - Company...Inc. today provided an update on its two Phase III programs evaluating two separate compounds...
Source: HighBeam Research, Phase III study for kidney cancer vaccine analyzed.